英格兰结节性痒疹的流行病学:一项回顾性数据库分析
该研究基于英国临床实践研究数据链与医院统计住院数据,描述英格兰结节性痒疹的流行病学。点患病率为每1万人口3.27例(95%CI 3.15-3.40),相当于2018年英格兰有18 471例患者;2008至2018年发病率为每10万患者年2.88例。特应性皮炎(52.2%)、抑郁(41.1%)和焦虑(35.4%)共病率较高。
要点
- 英格兰结节性痒疹点患病率为每1万人口3.27例(95%CI 3.15-3.40)。
- 2018年英格兰约有18 471例结节性痒疹患者。
- 2008至2018年发病率为每10万患者年2.88例。
核心结论
- 本研究支持将结节性痒疹归类为罕见病,英格兰患病率为每1万人口3.27例,相当于2018年有18 471例患者。
- 这些患者中共病患病率相对较高,可能增加管理复杂性。
研究设计与样本
- 研究利用临床实践研究数据链链接医院统计住院数据。
- 通过初级保健或住院数据集中临床编码选择结节性痒疹患者,病例定义基于至少两次不同诊断以最大化特异性。
- 计算2018年中点的点患病率,并呈现2008至2018年的发病率。
- 对认定为新发病例者报告人口学和临床特征。
- 敏感性分析中修改病例定义以放宽多次诊断标准,并将病例限制为在中点患病日期前后最多4年或10年内诊断者。
主要发现
- 数据集中共有11 656例患者至少有一次结节性痒疹诊断。
- 应用相关纳入标准后,2743例患者构成点患病队列;估计患病率为每1万人口3.27例(95%CI 3.15-3.40)。
- 敏感性分析中估计患病率范围为2.24(95%CI 2.14-2.34)至6.98(95%CI 6.80-7.16)。
- 研究期间发病率为每10万患者年2.88例。
- 该人群中合并症相对较高,尤其是特应性皮炎(52.2%)、抑郁(41.1%)和焦虑(35.4%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prurigo nodularis is a debilitating skin condition that is classified as rare by the Genetic and Rare Diseases Information Center (GARD) and the National Organization for Rare Diseases (NORD). There are currently no estimates of the prevalence of prurigo nodularis in England. OBJECTIVES: We aimed to address this data gap by describing the epidemiology of prurigo nodularis in a representative dataset derived from the English National Health Service. METHODS: The study utilized data from the Clinical Practice Research Datalink linked to Hospital Episode Statistics inpatient data. Patients with a diagnosis of prurigo nodularis were selected by clinical code in the primary care or inpatient datasets. Case definition was based on a minimum of two distinct diagnoses to maximize specificity. Point prevalence was calculated for the midpoint of 2018 and incidence rates from 2008 to 2018 were presented. For those classified as incident cases, demographic and clinical characteristics were reported. In sensitivity analyses the case definition was modified to relax the multiple diagnosis criteria and to restrict cases to those diagnosed within a maximum of 4 or 10 years of the midpoint prevalence date. RESULTS: Overall, 11 656 patients within the dataset had at least one prurigo nodularis diagnosis. Following application of the relevant inclusion criteria, 2743 patients formed the point prevalent cohort; the estimated prevalence was 3·27 patients per 10 000 population [95% confidence interval (CI) 3·15-3·40]. In sensitivity analyses the estimated prevalence ranged from 2·24 (95% CI 2·14-2·34) to 6·98 (95% CI 6·80-7·16). Incidence over the study period was 2·88 per 100 000 patient-years. Comorbidity was relatively high in this population, notably for atopic dermatitis (52·2%), depression (41·1%) and anxiety (35·4%). CONCLUSIONS: This study supports the NORD/GARD classification of prurigo nodularis as a rare disease with a prevalence of 3·27 patients per 10 000 population, which equates to 18 471 patients living with the disease in England in 2018. The relatively high prevalence of comorbidity observed for these patients may increase the complexity of management.
引用
- Morgan CL, Thomas M, Ständer S, et al. Epidemiology of prurigo nodularis in England: a retrospective database analysis. Br J Dermatol. 2022. PMID: 35083742. doi:10.1111/bjd.21032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。